News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,688 Results
Type
Article (64200)
Company Profile (310)
Press Release (679163)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (200921)
Career Advice (2979)
Deals (34899)
Drug Delivery (139)
Drug Development (85593)
Employer Resources (165)
FDA (17724)
Job Trends (15334)
News (348998)
Policy (35112)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2892)
Academic (2)
Accelerated approval (38)
Adcomms (35)
Allergies (159)
Alliances (52416)
ALS (185)
Alzheimer's disease (1822)
Antibody-drug conjugate (ADC) (347)
Approvals (17929)
Artificial intelligence (609)
Autoimmune disease (187)
Automation (44)
Bankruptcy (350)
Best Places to Work (11941)
BIOSECURE Act (21)
Biosimilars (208)
Biotechnology (214)
Bladder cancer (167)
Brain cancer (66)
Breast cancer (679)
Cancer (5164)
Cardiovascular disease (461)
Career advice (2529)
Career pathing (41)
CAR-T (313)
CDC (66)
Celiac Disease (2)
Cell therapy (846)
Cervical cancer (39)
Clinical research (72785)
Collaboration (1891)
Company closure (4)
Compensation (1015)
Complete response letters (77)
COVID-19 (2939)
CRISPR (102)
C-suite (912)
Cystic fibrosis (151)
Data (6535)
Decentralized trials (2)
Denatured (53)
Depression (154)
Diabetes (532)
Diagnostics (6955)
Digital health (48)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (294)
Drug pricing (212)
Drug shortages (32)
Duchenne muscular dystrophy (253)
Earnings (83709)
Editorial (65)
Employer branding (21)
Employer resources (150)
Events (111554)
Executive appointments (1037)
FDA (21029)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1582)
Gene editing (219)
Generative AI (62)
Gene therapy (688)
GLP-1 (1103)
Government (5174)
Grass and pollen (8)
Guidances (387)
Healthcare (19728)
HIV (74)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (303)
Immuno-oncology (70)
Indications (125)
Infectious disease (3254)
Inflammatory bowel disease (216)
Inflation Reduction Act (15)
Influenza (129)
Intellectual property (265)
Interviews (565)
IPO (16241)
IRA (57)
Job creations (3794)
Job search strategy (2056)
JPM (67)
Kidney cancer (18)
Labor market (78)
Layoffs (579)
Leadership (42)
Legal (8201)
Liver cancer (99)
Longevity (18)
Lung cancer (697)
Lymphoma (390)
Machine learning (45)
Management (55)
Manufacturing (846)
MASH (179)
Medical device (13916)
Medtech (13975)
Mergers & acquisitions (19743)
Metabolic disorders (1397)
mRNA (188)
Multiple sclerosis (175)
NASH (22)
Neurodegenerative disease (377)
Neuropsychiatric disorders (102)
Neuroscience (3197)
Neurotech (1)
NextGen: Class of 2026 (7020)
Non-profit (4979)
Now hiring (41)
Obesity (668)
Opinion (340)
Ovarian cancer (167)
Pain (220)
Pancreatic cancer (245)
Parkinson's disease (314)
Partnered (35)
Patents (534)
Patient recruitment (539)
Peanut (62)
People (58471)
Pharmaceutical (75)
Pharmacy benefit managers (31)
Phase 1 (22444)
Phase 2 (31788)
Phase 3 (24087)
Pipeline (5818)
Policy (333)
Postmarket research (2977)
Preclinical (9774)
Press Release (63)
Prostate cancer (265)
Psychedelics (59)
Radiopharmaceuticals (290)
Rare diseases (979)
Real estate (6081)
Recruiting (73)
Regulatory (26598)
Reports (42)
Research institute (2659)
Resumes & cover letters (481)
Rett syndrome (28)
RNA editing (20)
RSV (90)
Schizophrenia (164)
Series A (266)
Series B (203)
Service/supplier (7)
Sickle cell disease (108)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (45)
Startups (3651)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (87)
The Weekly (108)
Vaccines (1159)
Venture capital (95)
Weight loss (448)
Women's health (97)
Worklife (22)
Date
Today (208)
Last 7 days (835)
Last 30 days (2828)
Last 365 days (31062)
2026 (4837)
2025 (31266)
2024 (35954)
2023 (40436)
2022 (51632)
2021 (56195)
2020 (55139)
2019 (48298)
2018 (36648)
2017 (33915)
2016 (33634)
2015 (38733)
2014 (31998)
2013 (27964)
2012 (29487)
2011 (29679)
2010 (28645)
Location
Africa (1038)
Alabama (89)
Alaska (6)
Arizona (281)
Arkansas (15)
Asia (44532)
Australia (7592)
California (11424)
Canada (3330)
China (1188)
Colorado (494)
Connecticut (500)
Delaware (317)
Europe (101461)
Florida (1746)
Georgia (367)
Hawaii (3)
Idaho (61)
Illinois (920)
India (74)
Indiana (538)
Iowa (22)
Japan (451)
Kansas (123)
Kentucky (41)
Louisiana (29)
Maine (78)
Maryland (1422)
Massachusetts (8370)
Michigan (348)
Minnesota (613)
Mississippi (6)
Missouri (135)
Montana (36)
Nebraska (30)
Nevada (131)
New Hampshire (85)
New Jersey (3119)
New Mexico (29)
New York (3061)
North Carolina (1558)
North Dakota (10)
Northern California (5571)
Ohio (347)
Oklahoma (21)
Oregon (45)
Pennsylvania (2333)
Puerto Rico (25)
Rhode Island (45)
South America (1325)
South Carolina (69)
South Dakota (1)
Southern California (4450)
Tennessee (177)
Texas (1805)
United States (41135)
Utah (354)
Vermont (1)
Virginia (290)
Washington D.C. (79)
Washington State (941)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
743,688 Results for "centers for disease control and prevention cdc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Lilly Bests Novo Again, Rare Disease Week Goes Regulatory, More CDC Leadership Upheaval
Eli Lilly notches another win over Novo Nordisk, as Zepbound bests CagriSema in a head-to-head trial sponsored by Novo; The FDA kicked off Rare Disease Week, providing draft guidance on its new plausible mechanism pathway, while a bipartisan senate hearing on Thursday will focus on the authorization process for rare conditions; Another leadership change shakes up CDC; and Gilead acquires CAR T partner Arcellx for nearly $8 billion.
February 25, 2026
·
2 min read
·
Heather McKenzie
CDC
NIH’s Jay Bhattacharya Steps In as Acting CDC Chief
Jay Bhattacharya will become the latest leader of the CDC on an acting basis, days after Jim O’Neill stepped aside.
February 18, 2026
·
1 min read
·
Annalee Armstrong
Government
Kennedy Ally Departs CDC Amid Leadership Shake-Up
Ralph Abraham, a vocal vaccine skeptic who served at the agency for just three months, has stepped down due to “unforeseen family obligations,” according to the CDC.
February 23, 2026
·
1 min read
·
Annalee Armstrong
CDC
CDC Left Leaderless Again After Acting Director Departs HHS
Jim O’Neill was deputy secretary at the Department of Health and Human Services and also acting director of the CDC after the abrupt ouster of Susan Monarez in August 2025.
February 16, 2026
·
1 min read
·
Tristan Manalac
Podcast
Modernagate Fallout, Disc’s Rejection, Compass’ Psilocybin Data, CDC’s Lost Leaders
The FDA outright refuses to review Moderna’s mRNA-based flu vaccine as CBER director Vinay Prasad’s conduct is scrutinized; Disc Medicine receives an unexpected rejection, which Prasad may also have had a hand in; Compass Pathways posts new late-stage data on its psilocybin-based depression drug; CDC is once again leaderless.
February 18, 2026
·
1 min read
·
Heather McKenzie
Vaccines
CDC Formally Adopts Delayed Hepatitis B Vaccine Dose
The CDC accepted the recommendation of its advisory committee that the shot be delayed for many patients until they are at least two months of age due to safety concerns. The CDC itself has said the vaccine is safe and effective.
December 17, 2025
·
4 min read
·
Tristan Manalac
Vaccines
CDC Highlights Efficacy of COVID-19 Shots in Kids Amid FDA Probe of Alleged Deaths
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care visits in children aged 9 months through four years, according to a new report.
December 12, 2025
·
2 min read
·
Tristan Manalac
Government
Chaos at CDC Continues as Hundreds Fired, Rehired
The last few months have been tumultuous for the CDC, which has seen the ouster of Director Susan Monarez and all 17 members of the Advisory Committee on Immunization Practices.
October 13, 2025
·
2 min read
·
Tristan Manalac
Government
Amid ACIP Shake-Up, CDC Reinstates Hundreds of Fired Employees
The rehired staff, who number around 460, work with the CDC’s viral disease prevention efforts and sexual health testing labs, among others. The reinstatements are a ray of light in an acrimonious week that also saw protests and the complete overhaul of the agency’s vaccine advisory committee.
June 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness
February 18, 2026
·
4 min read
1 of 74,369
Next